title: MCH and apomorphine in combination enhance action potential firing of nucleus accumbens shell neurons in vitro.
abstract: The MCH and dopamine receptor systems have been shown to modulate a number of behaviors related to reward processing, addiction, and neuropsychiatric conditions such as schizophrenia and depression. In addition, MCH and dopamine receptors can interact in a positive manner, for example in the expression of cocaine self-administration. A recent report (Chung et al., 2011a) showed that the DA1/DA2 dopamine receptor activator apomorphine suppresses pre-pulse inhibition, a preclinical model for some aspects of schizophrenia. Importantly, MCH can enhance the effects of lower doses of apomorphine, suggesting that co-modulation of dopamine and MCH receptors might alleviate some symptoms of schizophrenia with a lower dose of dopamine receptor modulator and thus fewer potential side effects. Here, we investigated whether MCH and apomorphine could enhance action potential firing in vitro in the nucleus accumbens shell (NAshell), a region which has previously been shown to mediate some behavioral effects of MCH. Using whole-cell patch-clamp electrophysiology, we found that MCH, which has no effect on firing on its own, was able to increase NAshell firing when combined with a subthreshold dose of apomorphine. Further, this MCH/apomorphine increase in firing was prevented by an antagonist of either a DA1 or a DA2 receptor, suggesting that apomorphine acts through both receptor types to enhance NAshell firing. The MCH/apomorphine-mediated firing increase was also prevented by an MCH receptor antagonist or a PKA inhibitor. Taken together, our results suggest that MCH can interact with lower doses of apomorphine to enhance NAshell firing, and thus that MCH and apomorphine might interact in vivo within the NAshell to suppress pre-pulse inhibition.
authors: Ernest Gallo Clinic and Research Center, Department of Neurology, University of California , San Francisco, Emeryville, CA , USA.
authors: F Woodward
authors: FW
authors: Hopf
authors: Taban
authors: T
authors: Seif
authors: Shinjae
authors: S
authors: Chung
authors: Olivier
authors: O
authors: Civelli
keywords: Apomorphine; Dopamine receptor; MCH; Nucleus accumbens shell; Schizophrenia
references: Neuropsychopharmacology. 2012 Oct;37(11):2405-15
references: 22692565
references: Neuroscience. 2011 Oct 13;193:21-33
references: 21821098
references: Brain Res. 1997 Oct 31;773(1-2):45-52
references: 9409703
references: Behav Brain Res. 2009 Dec 7;204(2):396-409
references: 19110006
references: Psychopharmacology (Berl). 2008 Jun;198(2):261-70
references: 18389222
references: Neuropsychopharmacology. 2009 Jul;34(8):2041-52
references: 19262467
references: Pharmacol Biochem Behav. 2007 May;87(1):1-10
references: 17475315
references: Neuron. 2010 Mar 11;65(5):682-94
references: 20223203
references: PLoS One. 2011;6(7):e19286
references: 21818251
references: Eur Neuropsychopharmacol. 2008 Dec;18(12):888-96
references: 18760571
references: Neuropsychopharmacology. 2007 Feb;32(2):273-83
references: 16641946
references: Brain Res. 2012 Oct 2;1476:108-18
references: 22565012
references: Psychopharmacology (Berl). 2001 Jul;156(2-3):234-58
references: 11549226
references: Eur J Pharmacol. 2008 Dec 3;599(1-3):72-80
references: 18848539
references: J Neurosci. 2005 Jan 26;25(4):985-9
references: 15673680
references: J Neurosci. 2012 Jan 11;32(2):726-37
references: 22238108
references: Neuropsychopharmacology. 2012 Jun;37(7):1671-82
references: 22414814
references: Biol Psychiatry. 2006 Jun 15;59(12):1151-9
references: 16566899
references: Behav Brain Res. 2008 Jun 26;190(1):59-66
references: 18339434
references: J Neurosci. 2003 Jul 16;23(15):6245-54
references: 12867509
references: J Neurosci. 1997 Nov 1;17(21):8580-7
references: 9334429
references: Nat Neurosci. 2005 Jun;8(6):805-12
references: 15908948
references: J Neurosci. 2003 Jun 15;23(12):5079-87
references: 12832531
references: Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97
references: 12601500
references: Psychoneuroendocrinology. 2012 Oct;37(10):1630-45
references: 22029952
references: J Neurosci. 2010 Jun 16;30(24):8263-73
references: 20554878
references: Behav Brain Res. 2002 Dec 2;137(1-2):75-114
references: 12445717
references: Neuroscience. 2006 Oct 13;142(2):451-61
references: 16844308
references: J Pharmacol Exp Ther. 2007 Jul;322(1):23-9
references: 17468300
references: J Mol Neurosci. 2011 Jan;43(1):115-21
references: 20582487
references: J Physiol. 2012 Aug 15;590(16):3743-69
references: 22586226
references: PLoS One. 2011 May 05;6(5):e19600
references: 21573180
references: Neuroscience. 2000;97(3):469-77
references: 10828530
references: Eur J Neurosci. 2012 Aug;36(4):2521-32
references: 22780554
references: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6772-7
references: 19342492
references: Neurotox Res. 2008 Oct;14(2-3):169-83
references: 19073424
references: J Neurosci. 2004 Mar 24;24(12):2923-33
references: 15044531
references: Mol Pharmacol. 2002 Jul;62(1):119-26
references: 12065762
references: Neuropsychopharmacology. 2011 Jun;36(7):1421-32
references: 21430650
references: Neuropsychopharmacology. 2010 Nov;35(12):2346-56
references: 20686455
references: J Neurosci. 2001 Dec 1;21(23):9471-7
references: 11717381
references: Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):373-82
references: 11509194
references: Eur J Neurosci. 2012 Feb;35(4):614-22
references: 22321070
references: Annu Rev Pharmacol Toxicol. 2004;44:269-96
references: 14744247
references: Mol Brain. 2011 Jun 13;4:26
references: 21663703
references: J Neurosci. 2005 Mar 16;25(11):2933-40
references: 15772353
references: Physiol Rev. 1998 Jan;78(1):189-225
references: 9457173
references: Curr Neuropharmacol. 2006 Oct;4(4):277-91
references: 18654637
references: J Comp Neurol. 2001 Jun 18;435(1):26-40
references: 11370009
references: Physiol Behav. 2010 Nov 2;101(4):428-37
references: 20670637
references: Nature. 1993 Nov 25;366(6453):344-7
references: 8247128
references: J Neurosci. 1982 Apr;2(4):415-23
references: 6279796
references: J Neurosci. 1997 Aug 1;17(15):5697-710
references: 9221769
references: Neuropsychopharmacology. 2010 Jan;35(2):560-9
references: 19847161
references: Eur J Neurosci. 2010 Jun;31(11):1946-59
references: 20497469